Anteris Technologies Global Corp. (AVR) stock
AVRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$4.99−0.10 (-1.96%)
Close on Nov 20, 2026Market cap $486.32MP/E –Yield –
Anteris Technologies Global free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Anteris Technologies Global's free cash flow for the twelve months ending Sep 30, 2026 was -$93.48M. For fiscal 2025 it was -$79.76M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$79.76M | – |
| FY2024 | Dec 31, 2024 | -$63.51M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$24.29M | – |
| Q2 FY2026 | Jun 30, 2026 | -$21.45M | – |
| Q1 FY2026 | Mar 31, 2026 | -$28.82M | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.02M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.07M | – |
| Q1 FY2025 | Mar 31, 2025 | -$21.74M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.60M | – |
| Q3 FY2024 | Sep 30, 2024 | -$14.64M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.02M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.25M | – |
See a number that looks wrong?